Quality assessment of routine nuchal translucency measurements: A North American laboratory perspective

Genetics in Medicine

Volumn 10, Issue 2, 2008, Pages 131-138

  Palomaki, Glenn E ^a,g   Neveux, Louis M ^a   Donnenfeld, Alan ^b   Lee, Jo Ellen S ^c   McDowell, Geraldine ^d   Canick, Jacob A ^a   Summers, Anne ^e   Lambert Messerlian, Geralyn ^a   Kellner, Leonard H ^f   Zebelman, Arthur ^d   Haddow, James E ^a  

^a BROWN UNIVERSITY   (United States)

^b Genzyme Genetics   (United States)

^c GENZYME GENETICS   (United States)

^d LABORATORY CORPORATION OF AMERICA   (United States)

^e NORTH YORK GENERAL HOSPITAL   (Canada)

^f Lenetix Medical Screening Laboratory   (United States)

^g BROWN UNIVERSITY   (United States)

Author keywords

Down syndrome; Nuchal translucency; Prenatal screening; Quality assessment

Indexed keywords

ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; ECHOGRAPHY; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MEDICAL DOCUMENTATION; NEWBORN; NORTH AMERICA; NUCHAL TRANSLUCENCY MEASUREMENT; OBSERVATIONAL STUDY; PATIENT MONITORING; PRENATAL SCREENING; QUALITY CONTROL;

EID: 39449126602     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/GIM.0b013e3181616bf8     Document Type: Article

References (30)

1. ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol 2007;109:217-227.
2. Nicolaides KH, Azar G, Byrne D, Mansur C, et al. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ 1992;304:867-869.
3. Nicolaides KH, Brizot ML, Snijders RJ. Fetal nuchal translucency: ultrasound screening for fetal trisomy in the first trimester of pregnancy. Br J Obstet Gynaecol 1994;101:782-786.
4. Palomaki GE, Lambert-Messerlian GM, Canick JA. A summary analysis of Down syndrome markers in the late first trimester. Adv Clin Chem 2007;43:177-210.
5. Wald NJ, Rodeck C, Hackshaw AK, Walters J, et al. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). J Med Screen 2003;10:56-104.
6. Malone FD, Canick JA, Ball RH, Nyberg DA, et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005;353:2001-2011.
7. Snijders RJ, Thom EA, Zachary JM, Platt LD, et al. First-trimester trisomy screening: nuchal translucency measurement training and quality assurance to correct and unify technique. Ultrasound Obstet Gynecol 2002;19:353-359.
8. Nuchal Translucency Quality Review Program. Available at: https://www.ntqr.org/SM/default.aspx Accessed May 30, 2007.
9. Fetal Medicine Foundation United Kingdom. Available at: http://fetalmedicine.com/ffmf.htm Accessed May 30, 2007.
10. Fetal Medicine Foundation United States. Available at: http://fetalmedicine.com/usa/ Accessed May 30, 2007.
11. Fetal Medicine International. Available at: http://mfmedicine.com/ Accessed May 30, 2007.
12. Malone FD, Wald NJ, Canick JA, Ball RH, et al. Use of overall population, center-specific, and sonographer-specific nuchal translucency medians in Down syndrome screening: which is best? Am J Obstet Gynecol 2003;189:S232.
13. Knight GJ, Palomaki GE. Epidemiologic monitoring of prenatal screening for neural tube defects and Down syndrome. Clin Lab Med 2003;23:531-551, xi.
14. Hadlock FP, Shah YP, Kanon DJ, Lindsey JV. Fetal crown-rump length: reevaluation of relation to menstrual age (5-18 weeks) with high-resolution real-time US. Radiology 1992;182:501-505.
15. Spencer K, Bindra R, Nix AB, Heath V, et al. Delta-NT or NT MoM: which is the most appropriate method for calculating accurate patient-specific risks for trisomy 21 in the first trimester? Ultrasound Obstet Gynecol 2003;22:142-148.
16. Crossley JA, Aitken DA, Cameron AD, McBride E, et al. Combined ultrasound and biochemical screening for Down's syndrome in the first trimester: a Scottish multicentre study. BJOG 2002;109:667-676.
17. Schielen PC, van Leeuwen-Spruijt M, Belmouden I, Elvers LH, et al. Multi-centre first-trimester screening for Down syndrome in the Netherlands in routine clinical practice. Prenat Diagn 2006;26:711-718.
18. Gyselaers WJ, Vereecken AJ, Van Herck EJ, Straetmans DP, et al. Audit on nuchal translucency thickness measurements in Flanders, Belgium: a plea for methodological standardization. Ultrasound Obstet Gynecol 2004;24:511-515.
19. Malone FD. Nuchal translucency-based Down syndrome screening: barriers to implementation. Semin Perinatol 2005;29:272-276.
20. Wapner R, Thom E, Simpson JL, Pergament E, et al. First-trimester screening for trisomies 21 and 18. N Engl J Med 2003;349:1405-1413.
21. Pajkrt E, Mol BW, Boer K, Drogtrop AP, et al. Intra- and interoperator repeatability of the nuchal translucency measurement. Ultrasound Obstet Gynecol 2000;15:297-301.
22. Pandya PP, Altman DG, Brizot ML, Pettersen H, et al. Repeatability of measurement of fetal nuchal translucency thickness. Ultrasound Obstet Gynecol 1995;5:334-337.
23. Braithwaite JM, Kadir RA, Pepera TA, Morris RW, et al. Nuchal translucency measurement: training of potential examiners. Ultrasound Obstet Gynecol 1996;8:192-195.
24. Newey VR, Nassiri DK, Bhide A, Thilaganathan B. Nuchal translucency thickness measurement: repeatability using a virtual ultrasound scanner. Ultrasound Obstet Gynecol 2003;21:596-601.
25. Edwards A, Mulvey S, Wallace EM. The effect of image size on nuchal translucency measurement. Prenat Diagn 2003;23:284-286.
26. Teoh M, Meagher SE, Choong S, Shekleton P, et al. The effect of image size on screen-positive rates for nuchal translucency screening. BJOG 2006;113:479-481.
27. Fries N, Althuser M, Fontanges M, Talmant C, et al. Quality control of an image-scoring method for nuchal translucency ultrasonography. Am J Obstet Gynecol 2007;196:272, e271-e275.
28. Herman A, Dreazen E, Maymon R, Tovbin Y, et al. Implementation of nuchal translucency image-scoring method during ongoing audit. Ultrasound Obstet Gynecol 1999;14:388-392.
29. Wojdemann KR, Christiansen M, Sundberg K, Larsen SO, et al. Quality assessment in prospective nuchal translucency screening for Down syndrome. Ultrasound Obstet Gynecol 2001;18:641-644.
30. Evans MI, Van Decruyes H, Nicolaides KH. Nuchal translucency measurements for first-trimester screening: the 'price' of inaccuracy. Fetal Diagn Ther 2007;22:401-404.